- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
EFHD2 Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP9285b | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP9285b-ev20 | Ev20 size 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
EFHD2 Antibody (C-term) - Product info | |
| Application | WB, IHC, FC
|
| Primary Accession | Q96C19 |
| Other Accession | Q4FZY0, Q9D8Y0, A5D7A0 |
| Reactivity | Human |
| Predicted | Bovine, Mouse, Rat |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 26697 Da |
EFHD2 Antibody (C-term) - Additional info | |
| Gene ID 79180 | |
| Other Names EFHD2; SWS1; EF-hand domain-containing protein D2; Swiprosin-1 | |
| Target/Specificity This EFHD2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 203~232 amino acids from the C-terminal region of human EFHD2. | |
| Dilution WB~~1:100~500WB~~1:1000 IHC~~1:50~100 FC~~1:10~50 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions EFHD2 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
EFHD2 Antibody (C-term) - Protein Information | |
| Name EFHD2 | |
| Synonyms SWS1 | |
| Function May regulate B-cell receptor (BCR)-induced immature and primary B-cell apoptosis (By similarity). Plays a role as negative regulator of the canonical NF-kappa-B-activating branch (By similarity). Controls spontaneous apoptosis through the regulation of BCL2L1 abundance (By similarity) | |
| Cellular Location Membrane raft (By similarity). Note=In a mouse immature B-cell line WEHI-231 (By similarity) | |
| Tissue Location Found in lymphocytes; preferentially expressed in CD8+ cells | |
EFHD2 Antibody (C-term) - Related products
AP9285b: EFHD2 Antibody (C-term)
RI11693: EFHD2 predesign siRNA
EFHD2 Antibody (C-term) - Application data
-
Western blot analysis of EFHD2 Antibody (C-term) (Cat. #AP9285b) in HL-60 cell line lysates (35ug/lane). EFHD2 (arrow) was detected using the purified Pab.
-
Formalin-fixed and paraffin-embedded human testis tissue reacted with EFHD2 Antibody (C-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.
-
EFHD2 Antibody (C-term) (Cat. #AP9285b) flow cytometric analysis of HL-60 cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
EFHD2 Antibody (C-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
EFHD2 may regulate B-cell receptor (BCR)-induced immature and primary B-cell apoptosis. EFHD2 plays a role as negative regulator of the canonical NF-kappa-B-activating branch. This protein controls spontaneous apoptosis through the regulation of BCL2L1 abundance.
REFERENCES
Thylur,R.P., et.al., J. Cell. Biochem. 108 (3), 705-715 (2009) Martins-de-Souza,D., et.al., Eur Arch Psychiatry Clin Neurosci 259 (3), 151-163 (2009) Avramidou,A., et.al., Cell Death Differ. 14 (11), 1936-1947 (2007)